161 related articles for article (PubMed ID: 20521864)
1. Carcinogenic mode of action of folpet in mice and evaluation of its relevance to humans.
Cohen SM; Gordon EB; Singh P; Arce GT; Nyska A
Crit Rev Toxicol; 2010 Jul; 40(6):531-45. PubMed ID: 20521864
[TBL] [Abstract][Full Text] [Related]
2. Genetic toxicology of folpet and captan.
Arce GT; Gordon EB; Cohen SM; Singh P
Crit Rev Toxicol; 2010 Jul; 40(6):546-74. PubMed ID: 20569196
[TBL] [Abstract][Full Text] [Related]
3. Folpet-induced short term cytotoxic and proliferative changes in the mouse duodenum.
Gordon E; Cohen SM; Singh P
Toxicol Mech Methods; 2012 Jan; 22(1):54-9. PubMed ID: 22017358
[TBL] [Abstract][Full Text] [Related]
4. An adverse outcome pathway for small intestinal tumors in mice involving chronic cytotoxicity and regenerative hyperplasia: a case study with hexavalent chromium, captan, and folpet.
Bhat VS; Cohen SM; Gordon EB; Wood CE; Cullen JM; Harris MA; Proctor DM; Thompson CM
Crit Rev Toxicol; 2020 Sep; 50(8):685-706. PubMed ID: 33146058
[TBL] [Abstract][Full Text] [Related]
5. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
6. Formaldehyde and glutaraldehyde and nasal cytotoxicity: case study within the context of the 2006 IPCS Human Framework for the Analysis of a cancer mode of action for humans.
McGregor D; Bolt H; Cogliano V; Richter-Reichhelm HB
Crit Rev Toxicol; 2006; 36(10):821-35. PubMed ID: 17118731
[TBL] [Abstract][Full Text] [Related]
7. Development of a quantitative model incorporating key events in a hepatotoxic mode of action to predict tumor incidence.
Luke NS; Sams R; DeVito MJ; Conolly RB; El-Masri HA
Toxicol Sci; 2010 May; 115(1):253-66. PubMed ID: 20106946
[TBL] [Abstract][Full Text] [Related]
8. Chloroform mode of action: implications for cancer risk assessment.
Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
[TBL] [Abstract][Full Text] [Related]
9. A mechanistic interpretation of the oncogenicity of chlorothalonil in rodents and an assessment of human relevance.
Wilkinson CF; Killeen JC
Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 1):69-84. PubMed ID: 8921547
[TBL] [Abstract][Full Text] [Related]
10. Mode-of-action framework for evaluating the relevance of rodent forestomach tumors in cancer risk assessment.
Proctor DM; Gatto NM; Hong SJ; Allamneni KP
Toxicol Sci; 2007 Aug; 98(2):313-26. PubMed ID: 17426108
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Toxicity and Recovery in the Duodenum of B6C3F1 Mice Following Treatment with Intestinal Carcinogens Captan, Folpet, and Hexavalent Chromium.
Thompson CM; Wolf JC; McCoy A; Suh M; Proctor DM; Kirman CR; Haws LC; Harris MA
Toxicol Pathol; 2017 Dec; 45(8):1091-1101. PubMed ID: 29161989
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the carcinogenic potential of pesticides. 4. Chloroalkylthiodicarboximide compounds with fungicidal activity.
Quest JA; Fenner-Crisp PA; Burnam W; Copley M; Dearfield KL; Hamernik KL; Saunders DS; Whiting RJ; Engler R
Regul Toxicol Pharmacol; 1993 Feb; 17(1):19-34. PubMed ID: 8441825
[TBL] [Abstract][Full Text] [Related]
13. Cancer risk assessment for 1,3-butadiene: data integration opportunities.
Preston RJ
Chem Biol Interact; 2007 Mar; 166(1-3):150-5. PubMed ID: 16647696
[TBL] [Abstract][Full Text] [Related]
14. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M
Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
[TBL] [Abstract][Full Text] [Related]
15. Mode of action in relevance of rodent liver tumors to human cancer risk.
Holsapple MP; Pitot HC; Cohen SM; Boobis AR; Klaunig JE; Pastoor T; Dellarco VL; Dragan YP
Toxicol Sci; 2006 Jan; 89(1):51-6. PubMed ID: 16221960
[TBL] [Abstract][Full Text] [Related]
16. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of potential human carcinogenicity of the synthetic monomer ethyl acrylate.
Williams GM; Iatropoulos MJ
Regul Toxicol Pharmacol; 2009 Feb; 53(1):6-15. PubMed ID: 18930102
[TBL] [Abstract][Full Text] [Related]
18. Nitrapyrin: a scientific advisory group review of the mode of action and carcinogenicity in B6C3F1 mice.
Yano BL; Hardisty JF; Seely JC; Butterworth BE; McConnell EE; Swenberg JA; Williams GM; Stebbins KE; Golllapudi BB; Eisenbrandt DL
Regul Toxicol Pharmacol; 2008 Jun; 51(1):53-65. PubMed ID: 18367300
[TBL] [Abstract][Full Text] [Related]
19. Induction of gastrointestinal tumors in mice fed the fungicide folpet: possible mechanisms.
Nyska A; Waner T; Paster Z; Bracha P; Gordon EB; Klein B
Jpn J Cancer Res; 1990; 81(6-7):545-9. PubMed ID: 2119357
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]